Rampart Bioscience is evolving a new class of medicines for patients with genetically driven diseases. We integrate capabilities from a variety of key scientific disciplines — including gene delivery, protein sciences and clinical translation — to leap beyond the limitations of current gene therapies. Powered by our novel non-viral DNA delivery system, we are on a path to achieve higher standards for potency, durability, redosability and safety. Together, we are working to reshape the treatment landscape for people in dire need of better options.
| Website | https://rampartbio.com |
| Employees | 33 (33 on RocketReach) |
| Founded | 2019 |
| Address | 231 W Chestnut Ave, Monrovia, California 91016, US |
| Industry | Biotechnology Research |
| Keywords | Gene Editing, Gene Therapy, Novel Therapeutics, Genetic Diseases, Targeted Therapies, Gene Delivery, Clinical Translation, Biotechnology, Pharmaceutical, Drug Development, Biopharma, Precision Medicine, Rare Diseases, Molecular Medicine, Life Sciences, Therapeutic Development, Clinical Research, Biologics |
| Competitors | Roche, Thermo Fisher Scientific, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, Sema4, QIAGEN, Genomatix AG, BioSciencesCorp +45 more (view full list) |
Looking for a particular Rampart Bioscience employee's phone or email?
Rampart Bioscience Questions
Louis Breton is the CEO and Co-Founder of Rampart Bioscience.
33 people are employed at Rampart Bioscience.
Rampart Bioscience is based in Monrovia, California.
Top Rampart Bioscience Employees
-
Louis Breton
CEO and Co-Founder at Rampart Bioscience
Tucson, AZ, US45+ -
Jeffrey Bartlett
CTO and CIO and Co-Founder at Rampart Bioscience
Columbus, OH, US25+ -
Steven Lee
R and D Director at Rampart Bioscience
Pasadena, CA, US23
Related Companies
